Nucleolin, an abundant cellular protein, has been recognized as a therapeutic target in gene therapy treatments for cancer. Structural studies to facilitate rational design of small molecule inhibitors of nucleolin require sufficient quantities of the protein. Since cellular lev…
"1" Result
Sort By: